REFERENCE: J Clin Oncol 25:3061-3068 PIERRE GUILLOU, St James’ Hospital, Leeds COMMENT: DAVID JAYNE, St James’ Hospital, Leeds Laparoscopic-assisted resection for colorectal cancer has proved just as effective as conventional open surgery, according to researchers in
REFERENCE: Abstract K-1942, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007 RAMON GUEVARA, Los Angeles County Department of Public Health A report on a hospital outbreak involving a rare pathogen, which was presented at
REFERENCE: Abstract V-1385, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007 JUAN BERENGUER, Hospital Gregorio Marañón, Madrid A retrospective study has thrown doubt on the theory that protease inhibitors (PIs) are a preferable antiretroviral
REFERENCE: Abstract K-1373, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007 YEHUDA CARMELI, Tel-Aviv Medical Center Hospitals can prevent significant numbers of infections by taking up a multi-faceted approach, including the use of a
REFERENCE: Abstract H-717, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007 PEDRO CAHN, Juan A. Fernández Hospital, Buenos Aires Etravirine provides a chance to rescue patients who are failing non-nucleoside regimens according to 24-week
REFERENCE: Abstract K-1374, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007 LINDSAY GRAYSON, Austin Hospital, Victoria, Australia A hand hygiene campaign implemented in six hospitals in Victoria, Australia has saved lives from MRSA, and
REFERENCE: Slide Session C2-1360, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007 JANE HATA, bioMéríeux Inc, Durham Reports from the BORIS study call for ongoing surveillance of multi-drug resistant Acinetobacter
REFERENCE:47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007 MOIRA MCMAHON, Johns Hopkins University, Baltimore The hepatitis B drug entecavir appears to select for a drug resistant HIV mutation – and this has implications for
REFERENCE:47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007 JEFFREY JACOBSON, Drexel University College of Medicine, Philadelphia Could a monoclonal antibody have a role to play in HIV treatment? Early data on the PRO 140
REFERENCE:47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007 JACOB LALEZARI, Quest Clinical Research, San Francisco Maraviroc could be a useful new drug for the treatment of some HIV infections, according to Jacob Lalezari of
REFERENCE:47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007 DIANA LOCKWOOD, London School of Hygiene and Tropical Medicine ICAAC delegates heard that ‘hidden’ leprosy can be triggered in some patients who are receiving HIV antiretroviral
REFERENCE:47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007 GEORG HÄRTER, University Hospital, Ulm For patients with multiple myeloma being treated with the proteasome inhibitor bortezomib, doctor’s should be wary of viral reactivation – and
